α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability

Journal of Neurophysiology

Volumn 110, Issue 10, 2013, Pages 2358-2369

  Pidoplichko, Volodymyr I ^a   Prager, Eric M ^a   Aroniadou Anderjaska, Vassiliki ^a   Braga, Maria F M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

7 nAChR; Basolateral amygdala; GABAA receptor; Inhibition

Indexed keywords

AMPA RECEPTOR ANTAGONIST; BUNGAROTOXIN RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; NICOTINE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; BRAIN SLICE; COGNITION; CONTROLLED STUDY; EMOTIONALITY; EPILEPSY; FEAR; GABAERGIC SYSTEM; INTERNEURON; LEARNING; MALE; MEMORY; NERVE CELL EXCITABILITY; NONHUMAN; PATHOPHYSIOLOGY; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SCHIZOPHRENIA;

BASOLATERAL AMYGDALA; GABAA RECEPTOR; INHIBITION; Α7-NACHR;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; AMYGDALA; ANIMALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; INTERNEURONS; MALE; NERVE NET; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC POTENTIALS;

EID: 84887585196     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.01030.2012     Document Type: Article

References (112)

1. Addy NA, Nakijama A, Levin ED. Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala. Brain Res Cogn Brain Res 16: 51-57, 2003.
2. Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24: 189-202, 1998.
3. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89: 73-120, 2009.
4. Aleman A, Kahn RS. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol 77: 283-298, 2005.
5. Alkondon M, Albuquerque EX. Nicotinic acetylcholine receptor α7 and α4β2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus. J Neurophysiol 86: 3043-3055, 2001.
6. Alkondon M, Albuquerque EX. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog Brain Res 145: 109-120, 2004.
7. Alkondon M, Braga MF, Pereira EF, Maelicke A, Albuquerque EX. α7 Nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus. Eur J Pharmacol 393: 59-67, 2000.
8. Alkondon M, Pereira EF, Albuquerque EX. Age-dependent changes in the functional expression of two nicotinic receptor subtypes in CA1 stratum radiatum interneurons in the rat hippocampus. Biochem Pharmacol 74: 1134-1144, 2007.
9. Alkondon M, Pereira EF, Albuquerque EX. α-Bungarotoxin-and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res 810: 257-263, 1998.
10. Alkondon M, Pereira EF, Albuquerque EX. Mapping the location of functional nicotinic and gamma-aminobutyric acidA receptors on hippocampal neurons. J Pharmacol Exp Ther 279: 1491-1506, 1996.
11. Alkondon M, Pereira EF, Eisenberg HM, Albuquerque EX. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J Neurosci 19: 2693-2705, 1999.
12. Arnaiz-Cot JJ, Gonzalez JC, Sobrado M, Baldelli P, Carbone E, Gandia L, Garcia AG, Hernandez-Guijo JM. Allosteric modulation of alpha 7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission. Eur J Neurosci 27: 1097-1110, 2008.
13. Aroniadou-Anderjaska V, Fritsch B, Qashu F, Braga MF. Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy. Epilepsy Res 78: 102-116, 2008.
14. Aroniadou-Anderjaska V, Pidoplichko VI, Figueiredo TH, Almeida-Suhett CP, Prager EM, Braga MF. Presynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors. Neuroscience 221: 157-169, 2012.
15. Aroniadou-Anderjaska V, Qashu F, Braga MF. Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids 32: 305-315, 2007.
16. Barazangi N, Role LW. Nicotine-induced enhancement of glutamatergic and GABAergic synaptic transmission in the mouse amygdala. J Neurophysiol 86: 463-474, 2001.
17. Barik J, Wonnacott S. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol Pharmacol 69: 618-628, 2006.
18. Ben-Ari Y, Zigmond RE, Shute CC, Lewis PR. Regional distribution of choline acetyltransferase and acetylcholinesterase within the amygdaloid complex and stria terminalis system. Brain Res 120: 435-444, 1977.
19. Bencan Z, Levin ED. The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish. Physiol Behav 95: 408-412, 2008.
20. Benes FM. Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology 35: 239-257, 2010.
21. Boess FG, De Vry J, Erb C, Flessner T, Hendrix M, Luithle J, Methfessel C, Riedl B, Schnizler K, van der Staay FJ, van Kampen M, Wiese WB, Koenig G. The novel α7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents. J Pharmacol Exp Ther 321: 716-725, 2007.
22. Braga MF, Aroniadou-Anderjaska V, Manion ST, Hough CJ, Li H. Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala. Neuropsychopharmacology 29: 45-58, 2004.
23. Braga MF, Aroniadou-Anderjaska V, Xie J, Li H. Bidirectional modulation of GABA release by presynaptic glutamate receptor 5 kainate receptors in the basolateral amygdala. J Neurosci 23: 442-452, 2003.
24. Carlsen J, Heimer L. A correlated light and electron microscopic immunocytochemical study of cholinergic terminals and neurons in the rat amygdaloid body with special emphasis on the basolateral amygdaloid nucleus. J Comp Neurol 244: 121-136, 1986.
25. Carlsen J, Zaborszky L, Heimer L. Cholinergic projections from the basal forebrain to the basolateral amygdaloid complex: a combined retrograde fluorescent and immunohistochemical study. J Comp Neurol 234: 155-167, 1985.
26. Cheeta S, Irvine EE, Tucci S, Sandhu J, File SE. In adolescence, female rats are more sensitive to the anxiolytic effect of nicotine than are male rats. Neuropsychopharmacology 25: 601-607, 2001.
27. Christophe E, Roebuck A, Staiger JF, Lavery DJ, Charpak S, Audinat E. Two types of nicotinic receptors mediate an excitation of neocortical layer I interneurons. J Neurophysiol 88: 1318-1327, 2002.
28. Cohen A, Young RW, Velazquez MA, Groysman M, Noorbehesht K, Ben-Shahar OM, Ettenberg A. Anxiolytic effects of nicotine in a rodent test of approach-avoidance conflict. Psychopharmacology (Berl) 204: 541-549, 2009.
29. Dani JA. Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry 49: 166-174, 2001.
30. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47: 699-729, 2007.
31. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety? Biol Psychiatry 44: 1239-1247, 1998.
32. Davis M, Rainnie D, Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 17: 208-214, 1994.
33. Dickinson JA, Kew JN, Wonnacott S. Presynaptic alpha 7-and beta 2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms. Mol Pharmacol 74: 348-359, 2008.
34. Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann NY Acad Sci 877: 614-637, 1999.
35. Dziewczapolski G, Glogowski CM, Masliah E, Heinemann SF. Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. J Neurosci 29: 8805-8815, 2009.
36. Elmslie FV, Rees M, Williamson MP, Kerr M, Kjeldsen MJ, Pang KA, Sundqvist A, Friis ML, Chadwick D, Richens A, Covanis A, Santos M, Arzimanoglou A, Panayiotopoulos CP, Curtis D, Whitehouse WP, Gardiner RM. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet 6: 1329-1334, 1997.
37. Emson PC, Paxinos G, Le Gal La Salle G, Ben-Ari Y, Silver A. Choline acetyltransferase and acetylcholinesterase containing projections from the basal forebrain to the amygdaloid complex of the rat. Brain Res 165: 271-282, 1979.
38. Espana J, Gimenez-Llort L, Valero J, Minano A, Rabano A, Rodriguez-Alvarez J, LaFerla FM, Saura CA. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. Biol Psychiatry 67: 513-521, 2010.
39. Etkin A, Klemenhagen KC, Dudman JT, Rogan MT, Hen R, Kandel ER, Hirsch J. Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 44: 1043-1055, 2004.
40. Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 164: 1476-1488, 2007.
41. Feng HJ, Faingold CL. Repeated generalized audiogenic seizures induce plastic changes on acoustically evoked neuronal firing in the amygdala. Brain Res 932: 61-69, 2002.
42. Fenster CP, Rains MF, Noerager B, Quick MW, Lester RA. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17: 5747-5759, 1997.
43. Ferretti L, McCurry SM, Logsdon R, Gibbons L, Teri L. Anxiety and Alzheimer's disease. J Geriatr Psychiatry Neurol 14: 52-58, 2001.
44. Feuerbach D, Lingenhoehl K, Olpe HR, Vassout A, Gentsch C, Chaperon F, Nozulak J, Enz A, Bilbe G, McAllister K, Hoyer D. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology 56: 254-263, 2009.
45. Figueiredo TH, Aroniadou-Anderjaska V, Qashu F, Apland JP, Pidoplichko V, Stevens D, Ferrara TM, Braga MF. Neuroprotective efficacy of caramiphen against soman and mechanisms of its action. Br J Pharmacol 164: 1495-1505, 2011.
46. Gale GD, Anagnostaras SG, Godsil BP, Mitchell S, Nozawa T, Sage JR, Wiltgen B, Fanselow MS. Role of the basolateral amygdala in the storage of fear memories across the adult lifetime of rats. J Neurosci 24: 3810-3815, 2004.
47. Gloor P. Role of the amygdala in temporal lobe epilepsy. In: The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, edited by Aggleton JP. New York: Wiley-Liss, 1992, p. 505-538.
48. Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, Zoli M. Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 78: 703-711, 2009.
49. Guan ZZ, Zhang X, Blennow K, Nordberg A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport 10: 1779-1782, 1999.
50. Hall J, Whalley HC, McKirdy JW, Romaniuk L, McGonigle D, McIntosh AM, Baig BJ, Gountouna VE, Job DE, Donaldson DI, Sprengelmeyer R, Young AW, Johnstone EC, Lawrie SM. Overactivation of fear systems to neutral faces in schizophrenia. Biol Psychiatry 64: 70-73, 2008.
51. Hamann S, Monarch ES, Goldstein FC. Impaired fear conditioning in Alzheimer's disease. Neuropsychologia 40: 1187-1195, 2002.
52. Hamilton JP, Siemer M, Gotlib IH. Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol Psychiatry 13: 993-1000, 2008.
53. Hawkins JW. Antidepressant effects of nicotine. J Clin Psychiatry 58: 324-325, 1997.
54. 7-Nicotinic acetylcholine receptor: role in early odor learning preference in mice. PLoS One 7: e35251, 2012.
55. Hill JA Jr, Zoli M, Bourgeois JP, Changeux JP. Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit. J Neurosci 13: 1551-1568, 1993.
56. Hirsch E, Danober L, Simler S, Pereira de Vasconcelos A, Maton B, Nehlig A, Marescaux C, Vergnes M. The amygdala is critical for seizure propagation from brainstem to forebrain. Neuroscience 77: 975-984, 1997.
57. Hoefer M, Allison SC, Schauer GF, Neuhaus JM, Hall J, Dang JN, Weiner MW, Miller BL, Rosen HJ. Fear conditioning in frontotemporal lobar degeneration and Alzheimer's disease. Brain 131: 1646-1657, 2008.
58. Jiang L, Role LW. Facilitation of cortico-amygdala synapses by nicotine: activity-dependent modulation of glutamatergic transmission. J Neurophysiol 99: 1988-1999, 2008.
59. Kalappa BI, Gusev AG, Uteshev VV. Activation of functional alpha7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596. PLoS One 5: e13964, 2010.
60. Kassel JD, Unrod M. Smoking, anxiety, and attention: support for the role of nicotine in attentionally mediated anxiolysis. J Abnorm Psychol 109: 161-166, 2000.
61. 2+regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons. J Neurosci 23: 9024-9031, 2003.
62. Khiroug SS, Harkness PC, Lamb PW, Sudweeks SN, Khiroug L, Millar NS, Yakel JL. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J Physiol 540: 425-434, 2002.
63. Kishimoto K, Koyama S, Akaike N. Presynaptic modulation of synaptic gamma-aminobutyric acid transmission by tandospirone in rat basolateral amygdala. Eur J Pharmacol 407: 257-265, 2000.
64. Klein RC, Yakel JL. Functional somato-dendritic alpha7-containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex. J Physiol 576: 865-872, 2006.
65. Lang EJ, Pare D. Synaptic responsiveness of interneurons of the cat lateral amygdaloid nucleus. Neuroscience 83: 877-889, 1998.
66. Lawrie SM, Whalley HC, Job DE, Johnstone EC. Structural and functional abnormalities of the amygdala in schizophrenia. Ann NY Acad Sci 985: 445-460, 2003.
67. LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23: 727-738, 2003.
68. LeDoux JE. Emotion: clues from the brain. Annu Rev Psychol 46: 209-235, 1995.
69. Levin ED. α7-Nicotinic receptors and cognition. Curr Drug Targets 13: 602-606, 2012.
70. Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, Zhang J, Lucero L, Wang M, Sierks M, Hu G, Chang Y, Lukas RJ, Wu J. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. J Neurosci 29: 918-929, 2009.
71. Livingstone PD, Srinivasan J, Kew JN, Dawson LA, Gotti C, Moretti M, Shoaib M, Wonnacott S. α7 and non-α7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. Eur J Neurosci 29: 539-550, 2009.
72. Martin LF, Kem WR, Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) 174: 54-64, 2004.
73. Mash DC, Potter LT. Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain. Neuroscience 19: 551-564, 1986.
74. McDonald AJ, Mascagni F. Immunohistochemical characterization of somatostatin containing interneurons in the rat basolateral amygdala. Brain Res 943: 237-244, 2002.
75. McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Psychol 57: 521-546, 1995.
76. McKernan MG, Shinnick-Gallagher P. Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 390: 607-611, 1997.
77. Mitra R, Ferguson D, Sapolsky RM. SK2 potassium channel overexpression in basolateral amygdala reduces anxiety, stress-induced corticosterone secretion and dendritic arborization. Mol Psychiatry 14: 847-855, 827, 2009.
78. Muller J, Corodimas KP, Fridel Z, LeDoux JE. Functional inactivation of the lateral and basal nuclei of the amygdala by muscimol infusion prevents fear conditioning to an explicit conditioned stimulus and to contextual stimuli. Behav Neurosci 111: 683-691, 1997.
79. Muller JF, Mascagni F, McDonald AJ. Cholinergic innervation of pyramidal cells and parvalbumin-immunoreactive interneurons in the rat basolateral amygdala. J Comp Neurol 519: 790-805, 2011.
80. Nagai T, Kimura H, Maeda T, McGeer PL, Peng F, McGeer EG. Cholinergic projections from the basal forebrain of rat to the amygdala. J Neurosci 2: 513-520, 1982.
81. Nitecka L, Frotscher M. Organization and synaptic interconnections of GABAergic and cholinergic elements in the rat amygdaloid nuclei: singleand double-immunolabeling studies. J Comp Neurol 279: 470-488, 1989.
82. Ohshiro H, Kubota S, Murakoshi T. Dopaminergic modulation of oscillatory network inhibition in the rat basolateral amygdala depends on initial activity state. Neuropharmacology 61: 857-866, 2011.
83. Olincy A, Stevens KE. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. Biochem Pharmacol 74: 1192-1201, 2007.
84. Pape HC, Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev 90: 419-463, 2010.
85. Park K, Lee S, Kang SJ, Choi S, Shin KS. Hyperpolarization-activated currents control the excitability of principal neurons in the basolateral amygdala. Biochem Biophys Res Commun 361: 718-724, 2007.
86. Parri HR, Hernandez CM, Dineley KT. Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. Biochem Pharmacol 82: 931-942, 2011.
87. Pidoplichko VI, Dani JA. Applying small quantities of multiple compounds to defined locations of in vitro brain slices. J Neurosci Methods 142: 55-66, 2005.
88. Pitkanen A, Stefanacci L, Farb CR, Go GG, LeDoux JE, Amaral DG. Intrinsic connections of the rat amygdaloid complex: projections originating in the lateral nucleus. J Comp Neurol 356: 288-310, 1995.
89. Pitkanen A, Tuunanen J, Kalviainen R, Partanen K, Salmenpera T. Amygdala damage in experimental and human temporal lobe epilepsy. Epilepsy Res 32: 233-253, 1998.
90. Power AE. Muscarinic cholinergic contribution to memory consolidation: with attention to involvement of the basolateral amygdala. Curr Med Chem 11: 987-996, 2004.
91. Prager EM, Bergstrom HC, Grunberg NE, Johnson LR. The importance of reporting housing and husbandry in rat research. Front Behav Neurosci 5: 38, 2011.
92. Quarta D, Naylor CG, Barik J, Fernandes C, Wonnacott S, Stolerman IP. Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release. Psychopharmacology (Berl) 203: 399-410, 2009.
93. Rainnie DG. Serotonergic modulation of neurotransmission in the rat basolateral amygdala. J Neurophysiol 82: 69-85, 1999.
94. Rainnie DG, Mania I, Mascagni F, McDonald AJ. Physiological and morphological characterization of parvalbumin-containing interneurons of the rat basolateral amygdala. J Comp Neurol 498: 142-161, 2006.
95. Robinson L, Platt B, Riedel G. Involvement of the cholinergic system in conditioning and perceptual memory. Behav Brain Res 221: 443-465, 2011.
96. Rogan MT, Staubli UV, LeDoux JE. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390: 604-607, 1997.
97. Sah P, Faber ES, Lopez De Armentia M, Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 83: 803-834, 2003.
98. Segal M, Dudai Y, Amsterdam A. Distribution of an alpha-bungarotoxinbinding cholinergic nicotinic receptor in rat brain. Brain Res 148: 105-119, 1978.
99. Shin LM, Orr SP, Carson MA, Rauch SL, Macklin ML, Lasko NB, Peters PM, Metzger LJ, Dougherty DD, Cannistraro PA, Alpert NM, Fischman AJ, Pitman RK. Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry 61: 168-176, 2004.
100. Spampanato J, Polepalli J, Sah P. Interneurons in the basolateral amygdala. Neuropharmacology 60: 765-773, 2011.
101. Swanson LW, Simmons DM, Whiting PJ, Lindstrom J. Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system. J Neurosci 7: 3334-3342, 1987.
102. Szinyei C, Heinbockel T, Montagne J, Pape HC. Putative cortical and thalamic inputs elicit convergent excitation in a population of GABAergic interneurons of the lateral amygdala. J Neurosci 20: 8909-8915, 2000.
103. Szyndler J, Sienkiewicz-Jarosz H, Maciejak P, Siemiatkowski M, Rokicki D, Czlonkowska AI, Plaznik A. The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats. Pharmacol Biochem Behav 69: 511-518, 2001.
104. Tang J, Wotjak CT, Wagner S, Williams G, Schachner M, Dityatev A. Potentiated amygdaloid auditory-evoked potentials and freezing behavior after fear conditioning in mice. Brain Res 919: 232-241, 2001.
105. van der Zee EA, Luiten PG. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory. Prog Neurobiol 58: 409-471, 1999.
106. Van Kampen M, Selbach K, Schneider R, Schiegel E, Boess F, Schreiber R. AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors. Psychopharmacology (Berl) 172: 375-383, 2004.
107. Vazquez-Palacios G, Bonilla-Jaime H, Velazquez-Moctezuma J. Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine [correction of flouxetine]. Pharmacol Biochem Behav 78: 165-169, 2004.
108. Williams LR, Aroniadou-Anderjaska V, Qashu F, Finne H, Pidoplichko V, Bannon DI, Braga MF. RDX binds to the GABA(A) receptor-convulsant site and blocks GABAA receptor-mediated currents in the amygdala: a mechanism for RDX-induced seizures. Environ Health Perspect 119: 357-363, 2011.
109. Womble MD, Moises HC. Hyperpolarization-activated currents in neurons of the rat basolateral amygdala. J Neurophysiol 70: 2056-2065, 1993.
110. Woodruff AR, Sah P. Inhibition and synchronization of basal amygdala principal neuron spiking by parvalbumin-positive interneurons. J Neurophysiol 98: 2956-2961, 2007.
111. Woolf NJ. Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 37: 475-524, 1991.
112. Zhu PJ, Stewart RR, McIntosh JM, Weight FF. Activation of nicotinic acetylcholine receptors increases the frequency of spontaneous GABAergic IPSCs in rat basolateral amygdala neurons. J Neurophysiol 94: 3081-3091, 2005.